Scancell Holdings PLC (SCLP)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

12.50p

Buy

13.50p

arrow-up0.40p (+3.14%)

Prices updated at 27 Apr 2026, 17:00 BST

Prices minimum 15 mins delay

Prices in GBX

Scancell Holdings PLC is a biopharmaceutical company focused on the cancer therapeutics market. The company's principal activity consists of the discovery and development of monoclonal antibodies and vaccines for the treatment of cancer.

FTSE All-Share

-0.49%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	13.50p - 12.50p
	14.00p - 7.86p
	-
	132.32m
	-
	30,000
	1,140,554
	-
	1,056,593.93
	1.36
	1,036.78m
	GB00B63D3314
	-0.01
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.